- Resource Center
- PKD & Hereditary Kidney Disease
- Anemia Associated With CKD
- CKD & Related Comorbid Conditions
- End-Stage Kidney Disease & Renal Replacement Therapies
- Electrolyte Disorders
- Community Corners
- Physicians Corner
- Advanced Practice Providers Corner
- Nurses Corner
- Pharmacists Corner
- Dietitians Corner
- Payers Corner
Did you know that COVID-19 is affecting Black, Indigenous, Latinx and other people of color more than Caucasians? Did you know that in the United States, Black people are dying at 2.5 times the rate of White people?1
Please join us for a virtual panel discussion, led by nephrology and mental health experts from across the country, where you can hear about the intersectional effects of COVID-19 on both patients and the mental health of providers. Panelists will highlight the structural inequities that have led to racial disparities in both COVID-19 and nephrology care and discuss potential solutions to help bridge the gap.
1.The COVID Tracking Project. (2020). The COVID Racial Data Tracker. Retrieved July 30, 2020, from https://covidtracking.com/race/
*Speakers are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc (OPDC). Saba Gidey, PharmD, BCPS and Tazin Aijaz, PharmD, BCPS are employees of OPDC.
To register for this event please visit http://www.annasymposium.org/.
Dr. Hain is a Ph.D. trained, board certified adult and gerontological nurse practitioner who has practice experience within nephrology nursing, memory disorder clinic and hospice care. Dr. Hain’s scholarly endeavors have focused on improving health outcomes of older adults with chronic kidney disease and those with cognitive impairment, and she has authored numerous peer reviewed publications on these topics. Her current research interests are strategies to improve self-management in an ethnically diverse population with CKD Stage 4 and 5 and Supportive (Palliative) care of older adults with CKD stage 4-5 and ESRD. Dr. Hain’s teaching has focused on care of individuals with chronic disease such as diabetes, chronic kidney disease, pulmonary disease, and cognitive impairment.
Tazin Aijaz, PharmD, BCPS, is a Medical Science Liaison at Otsuka Pharmaceutical Development and Commercialization. She earned her PharmD from the University of Cincinnati in Cincinnati, Ohio. Dr. Aijaz then completed her clinical residency training at the Atlanta Veterans Affairs Medical Center. Prior to joining Otsuka, Dr. Aijaz held various positions within the pharmaceutical industry. Dr. Aijaz is board certified in pharmacotherapy.
Online Via AnnaSymposium.org
Overview Of Major Depressive Disorder (MDD) & Chronic Kidney Disease (CKD)/End-Stage Renal Disease (ESRD)August 19 from 6:30 pm to 7:30 pm
August 25 from 12:00 pm to 1:00 pm
August 26 from 11:00 am to 12:00 pm
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU 's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.May 2020 MRC2.CORP.X.04767
- Resource Center
- Community Corners